ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
131.743,58
-0,45%
S&P 500
5.753,57
1,52%
US Dollar vs BRL
5,7331
-0,03%
Bitcoin
88.088,90
2,35%
Brent Oil
72,525
0,95%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Danaher Corporation (DHR)

  7. Danaher Corporation (DHR) Notícias

DHR

Danaher (DHR)

Danaher Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:DHR
DataHoraFonteTítuloCódigoCompanhia
20/03/202517:15PR Newswire (US)Danaher Schedules First Quarter 2025 Earnings Conference CallNYSE:DHRDanaher Corporation
11/03/202517:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DHRDanaher Corporation
10/03/202509:30PR Newswire (US)Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay SystemNYSE:DHRDanaher Corporation
05/03/202519:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DHRDanaher Corporation
25/02/202518:15PR Newswire (US)Danaher to Present at TD Cowen Health Care ConferenceNYSE:DHRDanaher Corporation
24/02/202519:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:DHRDanaher Corporation
20/02/202518:45PR Newswire (US)Danaher Announces Appointment of Charles Lamanna to Danaher BoardNYSE:DHRDanaher Corporation
20/02/202518:19Edgar (US Regulatory)Form 8-K - Current reportNYSE:DHRDanaher Corporation
20/02/202518:15PR Newswire (US)Danaher Increases Quarterly DividendNYSE:DHRDanaher Corporation
29/01/202508:00PR Newswire (US)Danaher Reports Fourth Quarter and Full Year 2024 ResultsNYSE:DHRDanaher Corporation
21/01/202509:26Business WireAldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology for Research Grade ApplicationsNYSE:DHRDanaher Corporation
15/01/202510:30PR Newswire (US)Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease ResearchNYSE:DHRDanaher Corporation
13/01/202518:15PR Newswire (US)Danaher CEO to Comment on Financial PerformanceNYSE:DHRDanaher Corporation
09/01/202518:15PR Newswire (US)Danaher Announces Investment Partnership in Innovaccer Inc.NYSE:DHRDanaher Corporation
06/01/202518:15PR Newswire (US)Danaher to Present at J.P. Morgan Healthcare ConferenceNYSE:DHRDanaher Corporation
02/01/202518:05PR Newswire (US)Danaher Schedules Fourth Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
10/12/202418:15PR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
26/11/202419:00PR Newswire (US)Danaher to Present at Evercore ISI HealthCONx ConferenceNYSE:DHRDanaher Corporation
08/11/202410:23Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:DHRDanaher Corporation
22/10/202407:00PR Newswire (US)Danaher Reports Third Quarter 2024 ResultsNYSE:DHRDanaher Corporation
19/09/202417:30PR Newswire (US)Danaher Schedules Third Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
17/09/202409:30PR Newswire (US)Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term PartnershipNYSE:DHRDanaher Corporation
04/09/202417:30PR Newswire (US)Danaher Confirms Third Quarter and Full Year 2024 GuidanceNYSE:DHRDanaher Corporation
26/08/202418:30PR Newswire (US)Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C.NYSE:DHRDanaher Corporation
30/07/202408:30GlobeNewswire Inc.Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s DiseaseNYSE:DHRDanaher Corporation
25/07/202410:00PR Newswire (US)Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation CelebrationNYSE:DHRDanaher Corporation
23/07/202407:00PR Newswire (US)Danaher Reports Second Quarter 2024 ResultsNYSE:DHRDanaher Corporation
17/07/202408:30PR Newswire (US)Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine DevelopmentNYSE:DHRDanaher Corporation
16/07/202408:30PR Newswire (US)Danaher Releases 2024 Sustainability ReportNYSE:DHRDanaher Corporation
11/07/202408:30PR Newswire (US)Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug ScreeningNYSE:DHRDanaher Corporation
 Apresentando as notícias mais relevantes sobre:NYSE:DHR

Seu Histórico Recente

LATK
PAXGUSDT
Paxos Gold
EU
AEX4L
AEX X4 everage Net Return
Delayed Upgrade Clock
ADVFN Logo
Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios